about
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyIL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studySerum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy.Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.[Infectious diseases].Pathogenesis of sepsis: new concepts and implications for future treatment.Response prediction in chronic hepatitis C by assessment of IP-10 and IL28B-related single nucleotide polymorphisms.Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index.Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individualsClinical significance of the CCR5delta32 allele in hepatitis CA genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C.Polymorphisms in Toll-like receptor 4 (TLR4) are associated with protection against leprosyImpact of soluble CD26 on treatment outcome and hepatitis C virus-specific T cells in chronic hepatitis C virus genotype 1 infectionGenetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma developmentToll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosyHost genetic determinants of spontaneous hepatitis C clearance.Cytokines in septic shock.Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review.Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations.Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis.Innate immunogenetics: a tool for exploring new frontiers of host defence.IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance predictionToll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia.The recent breakthroughs in the understanding of host genomics in hepatitis C.Immunogenetics of invasive aspergillosis.Host factors and genetic susceptibility to infections due to intracellular bacteria and fastidious organisms.Host genetics of invasive Aspergillus and Candida infections.The swiss transplant cohort study: lessons from the first 6 years.Cytokines and Escherichia coli Sepsis.Human MicroRNA Responses Predict Cytomegalovirus Replication Following Solid Organ Transplantation.Host - hepatitis C viral interactions: The role of genetics.Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.A systematic review and meta-analysis of HCV clearance.Risk stratification and immunogenetic risk for infections following stem cell transplantationHost response to fungal infections - how immunology and host genetics could help to identify and treat patients at risk.Acute schistosomiasis: a risk underestimated by travelers and a diagnosis frequently missed by general practitioners-a cluster analysis of 42 travelers.A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease.Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.Bacillus cereus bacteraemia: comparison between haematologic and nonhaematologic patients
P50
Q28269827-75582FD1-AFD1-44BB-89C8-EB5E917A95F4Q28477057-570A8A5F-2F32-4D7C-A892-9B72B58244C0Q29417108-BC5543BD-22AE-437F-8669-418FF03FB412Q29417113-C55F3296-FD53-4D0E-A50C-2895A5EBEF30Q33409058-051DFDD0-4F91-4D7F-AF69-A28EEF038291Q33813681-2454FFE9-36CB-4BD6-B963-08A2DC63DC27Q33842239-F9E3749C-BDB0-48D7-8E55-26000D0910CDQ33981739-60163BFF-5C78-40EA-80BA-02EC27A17986Q34056881-84276800-1878-4B88-BC46-98BFDED49F3AQ34142349-FB5FE7AA-77D0-439F-A301-8D0DE08869C8Q34341819-51192E23-EC11-4BAE-AC98-665657C14AFCQ34470593-0A06CA48-B6E8-4A47-B19C-3A2348A2559EQ34599847-BB9A7855-6F2E-4156-BCC7-F4EB6EB5EB9BQ34755326-221E319E-2103-4FD0-933F-A4FAAA0AC69EQ34797664-5B0AFB2F-980A-4F62-8C8D-250F3B8A4619Q35011376-239BDC36-720D-4B35-A961-6BAC98382811Q35042317-BAB7FF96-8CAD-4D2F-BD01-69096541E616Q35948788-B2AB5B12-FDBD-4582-B133-72F5BAD05098Q36176018-7CF3D632-95DB-461E-8B38-644B816E42F1Q36770589-2F7C62D3-6B02-4BFB-ACE5-ABDA321B75FCQ36889564-31A3931F-7FCC-46B1-B14D-463251D48A8EQ36907926-642BC515-4CC0-40EA-AE7D-BDD35BD48F9BQ37130676-19B5E3EC-0F52-41A7-8F65-D4EEA8454D2AQ37481373-F92C42A2-9B5F-498F-BC40-9951693BF47CQ37771963-CD1BFAED-26D8-45BA-87B9-F7986BDD9FA1Q37788693-89FAB39E-635B-4127-A962-F38DFFCA71B5Q38264672-FA4A7038-00D0-499D-AAB7-820A28C0FC89Q38268925-596DFDEB-0F58-4544-8AF0-164DECA8FD81Q38444815-4B2CBD68-1F01-41AD-B44B-589EF2B4D0EDQ38601046-300210F9-385F-489F-BBD4-01E4AE93D5A0Q38724913-4CDFB70F-9A01-44F0-AC48-0ED4A58E4242Q38819965-D4ACA70C-3071-43D1-8335-CA5B4F477473Q38926063-D2BC42B7-A2BD-4D39-A4E0-DE0139AA6A7FQ38928083-3871EC2D-327F-47A5-AE3F-3A30C5BC8002Q38950315-7B86F44D-2823-4DCF-9BB4-AC3F29815063Q38961261-CD3342B9-EA3D-48C3-9DA2-A6B3EF9FE485Q39197328-8144CFBD-56E0-47EF-8197-2E570F18CDB1Q39459567-BCE5C9F3-6EB2-4DBD-93CC-A4E8952A7845Q39961908-B82B2B6C-7F42-4AA4-828E-11608B86471CQ40031834-2EBE20EF-E6E1-4C20-8208-76E7DF8D5C73
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pierre-Yves Bochud
@ast
Pierre-Yves Bochud
@en
Pierre-Yves Bochud
@es
Pierre-Yves Bochud
@nl
Pierre-Yves Bochud
@sl
type
label
Pierre-Yves Bochud
@ast
Pierre-Yves Bochud
@en
Pierre-Yves Bochud
@es
Pierre-Yves Bochud
@nl
Pierre-Yves Bochud
@sl
prefLabel
Pierre-Yves Bochud
@ast
Pierre-Yves Bochud
@en
Pierre-Yves Bochud
@es
Pierre-Yves Bochud
@nl
Pierre-Yves Bochud
@sl
P106
P21
P31
P496
0000-0002-2208-4757